The U.S. House of Representatives has passed a revised bipartisan bill that would make it easier for researchers to study marijuana. The bill was passed Tuesday by a vote of 325 to 95. The Medical Marijuana and Cannabidiol Research Act (H.R. 8454) now goes to the Senate, where it is expected to pass. The measure is expected to be the first stand-alone marijuana bill to be signed into law. The measure does streamline the research application process and removes barriers for the FDA. The measure could bring more business opportunities to the current state legal market and more bipartisan support for marijuana legalization at the federal level, according to the researchers' findings. House Republicans passed the study bill by a 109-95 margin; Democrats voted 216 to 0 in favor of the measure. Iowa Republican Senator and senior member of the Senate Charles Grassley released a statement after House passage reflecting how marijuana research has strong bipartisan support in the Senate. "This bipartisan bill is critical to better understanding the cannabis plant and its potential benefits and harms," Grassley said in the statement. "It would authorize the FDA to analyze CBD and medical marijuana products in a safe and responsible manner so that the American public can decide whether to use them in the future based on sound scientific data.
Information source: mjbizdaily.com/